New Data Show Patients Treated with TREMFYA®▼ (guselkumab) Achieve Durable Efficacy Across Joint and Axial Symptoms of Active Psoriatic Arthritis Through Two Years
- EMEA Innovative Medicine
- New Data Show Patients Treated with TREMFYA®▼ (guselkumab) Achieve Durable Efficacy Across Joint and Axial Symptoms of Active Psoriatic Arthritis Through Two Years
New Data Show Patients Treated with TREMFYA®▼ (guselkumab) Achieve Durable Efficacy Across Joint and Axial Symptoms of Active Psoriatic Arthritis Through Two Years
- X (Twitter)
Copy link